Literature DB >> 16005367

Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.

Seung Won Lee1, Kyoung Eun Song, Dong Sun Shin, Sung Min Ahn, Eun Suk Ha, Dae Jung Kim, Moon Suk Nam, Kwan-Woo Lee.   

Abstract

BACKGROUND AND AIM: In vivo and in vitro experimental findings indicate that the hyperglycemic diabetic milieu can induce altered expression of the matrix metalloproteinase (MMP) genes and contribute to imbalances in vascular matrix homeostasis. We examined the plasma levels of enzymes and inhibitors involved in extracellular matrix turnover.
METHODS: We measured the plasma concentrations of MMP-2, MMP-9, and tissue inhibitor of metalloproteinase 1 (TIMP-1) in 80 type-2 diabetic subjects without uremia and in 80 age-matched controls. In addition, we determined the plasma levels of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and high sensitive(hs) C-reactive protein (CRP) in both groups.
RESULTS: Plasma MMP-2, TIMP-1, and hs-CRP concentrations were significantly elevated in diabetic patients as compared to the control subjects (p<0.05). Plasma levels of MMP-2, MMP-9, TIMP-1, VCAM-1, ICAM-1, and hs-CRP were found not to be significantly associated with age, duration of diabetes, blood pressure, or serum lipid concentrations.
CONCLUSIONS: Plasma MMP-2, TIMP-1 and hs-CRP concentrations were significantly increased in type-2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005367     DOI: 10.1016/j.diabres.2004.12.010

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  20 in total

1.  Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes.

Authors:  Ian B McKittrick; Yolanda Bogaert; Kristen Nadeau; Janet Snell-Bergeon; Amber Hull; Tao Jiang; Xiaoxin Wang; Moshe Levi; Karen S Moulton
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-14

2.  Detection of protease activities by flash chronopotentiometry using a reversible polycation-sensitive polymeric membrane electrode.

Authors:  Kebede L Gemene; Mark E Meyerhoff
Journal:  Anal Biochem       Date:  2011-04-29       Impact factor: 3.365

3.  Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs.

Authors:  Lin Lu; Qi Zhang; Li Jin Pu; Wen Hui Peng; Xiao Xiang Yan; Lin Jie Wang; Qiu Jing Chen; Zheng Bing Zhu; Jean-Baptiste Michel; Wei Feng Shen
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

4.  Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice.

Authors:  P K Kamat; A Kalani; S Givvimani; P B Sathnur; S C Tyagi; N Tyagi
Journal:  Neuroscience       Date:  2013-07-31       Impact factor: 3.590

5.  Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.

Authors:  Carlos Fernandez-Patron; Dickson Leung
Journal:  Metalloproteinases Med       Date:  2015-08-13

6.  Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Vijay Viswanathan; Shanmugam Sivakumar; Syed Hissar; Hardy Kornfeld; Subash Babu
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-04-22

7.  High Sensitivity C - Reactive Protein is Associated with Diastolic Dysfunction in Young African Americans without Clinically Evident Cardiac Disease.

Authors:  Venkataraman Rajaram; Arthur T Evans; Gloria C Caldito; Russell F Kelly; Leon Fogelfeld; Henry R Black; Rami Doukky
Journal:  Open Cardiovasc Med J       Date:  2011-08-22

8.  Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome.

Authors:  Jolanta Mieczkowska; Jerzy Mosiewicz; Wojciech Barud; Wojciech Kwaśniewski
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

9.  Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin.

Authors:  Hai-Cheng Gao; Kun Zhu; Hai-Mei Gao; Chun-Sheng Miao; LE-Ning Zhang; Wei Liu; Hua Xin
Journal:  Exp Ther Med       Date:  2015-01-28       Impact factor: 2.447

Review 10.  Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Authors:  Camelia R Ban; Stephen M Twigg
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.